Download PDF
Thromb Haemost 1995; 74(02): 802-803
DOI: 10.1055/s-0038-1649821
Letter to the Editor
Schattauer GmbH Stuttgart

Treatment of Fulminant Meningococcemia with Recombinant Tissue Plasminogen Activator

Werner Zenz
Department of Pediatries, University of Graz, Graz, Austria
,
Wolfgang Muntean
Department of Pediatries, University of Graz, Graz, Austria
,
Gerfried Zobel
Department of Pediatries, University of Graz, Graz, Austria
,
Hans M Grubbauer
Department of Pediatries, University of Graz, Graz, Austria
,
Siegfried Gallistl
Department of Pediatries, University of Graz, Graz, Austria
› Author Affiliations
Further Information

Publication History

Received 08 February 1995

Accepted 05 April 1995

Publication Date:
06 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Fijnvandraat K, Derkx B, Peters M, Bijlmer R, Sturk A, Prins MH, van Deventer SJ H, ten Cate JW. Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality. Thromb Haemost 1995; 73: 15-20
    Thieme ConnectPubMedSearch in Google Scholar
  • 2 Brandtzaeg P, Joo GB, Brusletto B, Kierulf P. Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb Res 1990; 57: 271-278
    CrossrefPubMedSearch in Google Scholar
  • 3 Francis RB. Acquired purpura fulminans. Semin Thromb Haemost 1990; 16: 310-325
    Thieme ConnectPubMedSearch in Google Scholar
  • 4 Künzer W, Sutor AH, Niederhoff H, Pringheim W, Karitzky D, Altemcyer KH, Schenck W, Schreiber R. Gerinnungsphysiologisehe Aspekte and fibrinolytische Therapic des Schocks. Mschr Kindcrheilkd 1974; 122: 116-126
    PubMedSearch in Google Scholar
  • 5 Jäger D, Drews S, Hüppe D, Machraoui A, Krieg M, Barmeyer J. Erfolgreiche Fibrinolysetherapie der frühzcilig diagnoslizierten Cumarinnckrose. Med Klin 1992; 87: 334-338
    PubMedSearch in Google Scholar
  • 6 Markwardt Nowak G. Experimental fibrinolytic therapy of localised microthrombosis. Fibrinolysis 1987; 1: 121-122
    PubMedSearch in Google Scholar
  • 7 Condie RM, Hong CY, Good RA. Reversal of the lesions of the generalized Schwartzman phenomen by treatment of rabbits with streptokinase. J Lab Clin Med 1957; 50: 803-804
    PubMedSearch in Google Scholar
  • 8 Zenz W, Muntean W, Gallistl S, Zobel G, Grubbauer HM. Recombinant tissue plasminogen activator (rt-PA) treatment in two infants with fulminant meningococcemia. Pediatrics. 1995 (in press)
    PubMedSearch in Google Scholar
  • 9 Sinclair JF, Skeoch CM, Hallworh D. Prognosis of meningococcal septicaemia. Lancet 1987; 2: 38
    PubMedSearch in Google Scholar
  • 10 Zenz W, Muntean W, Beitzke A, Zobel G, Riccabona M, Gamillscheg A. Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterization in infants and children. Br Heart J 1993; 70: 382-385
    CrossrefPubMedSearch in Google Scholar
  • 11 Zenz W, Muntean W. Fibrinolytic therapy in children. Librinolysis 1995; 9 Suppl (Suppl. 01) 33-36
    PubMedSearch in Google Scholar
  • 12 Powars D, Larsen R, Johnson J, Hulbert T, Sun T, Patch MJ, Brands R, Chan L. Epidemic meningococcemia and purpura fulminans with induced protein C deficiency. Clin Infect Dis 1993; 17: 254-261
    CrossrefPubMedSearch in Google Scholar